Euronext announces volumes for November 2017

Back

Amsterdam, Brussels, Lisbon, London and Paris – 05 December 2017 – Euronext, the leading pan-European exchange in the Eurozone, today announced trading volumes for November 2017.

Cash Trading
In November 2017, the average daily transaction value on the Euronext cash order book stood at €8,141 million, up +11.0% compared to November 2016 and up +13.5% from the previous month. The average daily transaction value on ETFs was €481 million, down -22.1% compared to November 2016 and up +21.6% from the previous month. Euronext’s ETF offering slightly decreased this month to 828 listings at the end of November, compared to 831 at the end of the previous month. As a reminder, 790 ETFs were listed on Euronext markets at the end of 2016.

Derivatives trading
In November 2017, the overall average daily volume on derivatives reached 629,767 contracts, up +15.9% compared to November 2016 and up +26.5% compared to the previous month.  In details,

  • the average daily volume on equity index derivatives reached 219,503 contracts, down -7.0% compared to November 2016 and +14.5% from the previous month,
  • the average daily volume on individual equity derivatives reached 350,175 contracts in November 2017, up +37.0% compared to November 2016 and +32.1% from the previous month,
  • the average daily volume on commodities derivatives reached 60,089 contracts, up +16.6% compared to November 2016 and +46.9% from the previous month.

On a year-to-date basis, at end of November 2017, the overall average daily volume on Euronext derivatives stands at 551,326 contracts (+11.9% compared to end of November 2016) and the open interest was up at 19,727,262 contracts (+17.8% compared to end of November 2016).

FX spot trading
The average daily volume on the spot foreign exchange market of FastMatch, of which Euronext owns 90% of the capital since August 2017, stood at $17,777 million, up +3.9% compared to November 2016 and down -1.4% from the previous month.

Listing
In November 2017, Euronext had one technical listing, Reinet Investments on Euronext Amsterdam. In addition, €3.3 billion were raised on Euronext in corporate bonds and €2.0 billion of follow-on equity, including Eurofins Scientific €299m private placement and Erytech Pharma €107m capital increase.

Please refer to appendix tables for more details.

Appendix Tables: Euronext Cash Markets Monthly Activity; Euronext Derivatives Monthly Activity; FastMatch Monthly Activity.

Press Release Footer

About Euronext 
Euronext is the leading pan-European market infrastructure, connecting European economies to global capital markets, to accelerate innovation and sustainable growth. It operates regulated exchanges in Belgium, France, Ireland, Italy, the Netherlands, Norway and Portugal. With nearly 1,900 listed issuers and around €6.6 trillion in market capitalisation as of end December 2023, it has an unmatched blue-chip franchise and a strong diverse domestic and international client base. Euronext operates regulated and transparent equity and derivatives markets, one of Europe’s leading electronic fixed income trading markets and is the largest centre for debt and funds listings in the world. Its total product offering includes Equities, FX, Exchange Traded Funds, Warrants & Certificates, Bonds, Derivatives, Commodities and Indices. The Group provides a multi-asset clearing house through Euronext Clearing, and custody and settlement services through Euronext Securities central securities depositories in Denmark, Italy, Norway and Portugal. Euronext also leverages its expertise in running markets by providing technology and managed services to third parties. In addition to its main regulated market, it also operates a number of junior markets, simplifying access to listing for SMEs.  
For the latest news, follow us on Twitter (twitter.com/euronext) and LinkedIn (linkedin.com/euronext).

Disclaimer
This press release is for information purposes only and is not a recommendation to engage in investment activities. This press release is provided “as is” without representation or warranty of any kind. While all reasonable care has been taken to ensure the accuracy of the content, Euronext does not guarantee its accuracy or completeness. Euronext will not be held liable for any loss or damages of any nature ensuing from using, trusting or acting on information provided. No information set out or referred to in this publication may be regarded as creating any right or obligation. The creation of rights and obligations in respect of financial products that are traded on the exchanges operated by Euronext’s subsidiaries shall depend solely on the applicable rules of the market operator. All proprietary rights and interest in or connected with this publication shall vest in Euronext.

This press release speaks only as of this date. Euronext refers to Euronext N.V. and its affiliates. Information regarding trademarks and intellectual property rights of Euronext is located at www.euronext.com/terms-use.

© 2024, Euronext N.V. - All rights reserved.